Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melih Özişik

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Noro Psikiyatri Arsivi|September 26, 2022
Successful Rapid Drug Desensitization with A Modified Protocol To Alemtuzumab in A Multiple Sclerosis Patient with Severe Immediate-Type Hypersensitivity ReactionCeyda Tunakan Dalgiç, Emine Nihal Mete Gökmen, Melih Özişik, et al.
Biomed Research International|September 2, 2014
Hypervolemia for hypertension pathophysiology: a population-based studyEnder Hür, Melih Özişik, Cihan Ural, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Noro Psikiyatri Arsivi|September 26, 2022
Successful Rapid Drug Desensitization with A Modified Protocol To Alemtuzumab in A Multiple Sclerosis Patient with Severe Immediate-Type Hypersensitivity ReactionCeyda Tunakan Dalgiç, Emine Nihal Mete Gökmen, Melih Özişik, et al.
Biomed Research International|September 2, 2014
Hypervolemia for hypertension pathophysiology: a population-based studyEnder Hür, Melih Özişik, Cihan Ural, et al.
Pageof 1